Filing Details
- Accession Number:
- 0001209191-12-040243
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-08-03 16:15:10
- Reporting Period:
- 2012-08-02
- Filing Date:
- 2012-08-03
- Accepted Time:
- 2012-08-03 16:15:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1041197 | Neal Moszkowski | 311 C Enterprise Dr Plainsboro NJ 08536 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-08-02 | 12,500 | $35.76 | 16,011 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-08-02 | 12,500 | $36.34 | 3,511 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-08-02 | 7,500 | $0.00 | 7,500 | $35.76 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-08-02 | 5,000 | $0.00 | 5,000 | $35.76 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,000 | 2012-08-09 | No | 4 | M | Direct | |
0 | 2012-08-09 | No | 4 | M | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $36.11 to $36.75.
- 100% of the stock options vested on 2/9/2007, 6 months from the grant date of 8/9/2006